{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:43:09Z","timestamp":1788997389288,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00018-022-04350-x","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T17:05:54Z","timestamp":1654794354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["EIF4A3-induced circFIP1L1 represses miR-1253 and promotes radiosensitivity of nasopharyngeal carcinoma"],"prefix":"10.1007","volume":"79","author":[{"given":"Xiangqi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3546-5639","authenticated-orcid":false,"given":"Sanyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"issue":"3","key":"4350_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.soc.2015.03.008","volume":"24","author":"SC Kamran","year":"2015","unstructured":"Kamran SC, Riaz N, Lee N (2015) Nasopharyngeal carcinoma. Surg Oncol Clin N Am 24(3):547\u2013561","journal-title":"Surg Oncol Clin N Am"},{"issue":"6","key":"4350_CR2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"29","key":"4350_CR3","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1200\/JCO.2015.60.9347","volume":"33","author":"AW Lee","year":"2015","unstructured":"Lee AW, Ma BB, Ng WT, Chan AT (2015) Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol 33(29):3356\u20133364","journal-title":"J Clin Oncol"},{"issue":"3","key":"4350_CR4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ijrobp.2010.03.024","volume":"80","author":"SZ Lai","year":"2011","unstructured":"Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ et al (2011) How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 80(3):661\u2013668","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4350_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/annonc\/mdu507","volume":"26","author":"YP Chen","year":"2015","unstructured":"Chen YP, Wang ZX, Chen L, Liu X, Tang LL, Mao YP et al (2015) A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. Ann Oncol 26(1):205\u2013211","journal-title":"Ann Oncol"},{"issue":"3","key":"4350_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","volume":"105","author":"AW Lee","year":"2019","unstructured":"Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC et al (2019) International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 105(3):567\u2013580","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4350_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.21037\/cco.2018.04.05","volume":"7","author":"ELL Yeo","year":"2018","unstructured":"Yeo ELL, Li YQ, Soo KC, Wee JTS, Chua MLK (2018) Combinatorial strategies of radiotherapy and immunotherapy in nasopharyngeal carcinoma. Chin Clin Oncol 7(2):15","journal-title":"Chin Clin Oncol"},{"key":"4350_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.01.010","volume":"187","author":"B Han","year":"2018","unstructured":"Han B, Chao J, Yao H (2018) Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol Ther 187:31\u201344","journal-title":"Pharmacol Ther"},{"issue":"5","key":"4350_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/onc.2017.361","volume":"37","author":"LS Kristensen","year":"2018","unstructured":"Kristensen LS, Hansen TB, Veno MT, Kjems J (2018) Circular RNAs in cancer: opportunities and challenges in the field. Oncogene 37(5):555\u2013565","journal-title":"Oncogene"},{"key":"4350_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.canlet.2018.01.011","volume":"418","author":"B Chen","year":"2018","unstructured":"Chen B, Huang S (2018) Circular RNA: An emerging non-coding RNA as a regulator and biomarker in cancer. Cancer Lett 418:41\u201350","journal-title":"Cancer Lett"},{"issue":"1","key":"4350_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-018-0932-8","volume":"18","author":"H Xu","year":"2019","unstructured":"Xu H, Wang C, Song H, Xu Y, Ji G (2019) RNA-Seq profiling of circular RNAs in human colorectal cancer liver metastasis and the potential biomarkers. Mol Cancer 18(1):8","journal-title":"Mol Cancer"},{"issue":"7","key":"4350_CR12","first-page":"2817","volume":"23","author":"L Zhu","year":"2019","unstructured":"Zhu L, Liu Y, Yang Y, Mao XM, Yin ZD (2019) CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p. Eur Rev Med Pharmacol Sci 23(7):2817\u20132826","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"4350_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12943-020-01149-x","volume":"19","author":"X Hong","year":"2020","unstructured":"Hong X, Liu N, Liang Y, He Q, Yang X, Lei Y et al (2020) Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1. Mol Cancer 19(1):33","journal-title":"Mol Cancer"},{"key":"4350_CR14","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.2147\/OTT.S249202","volume":"13","author":"M Shuai","year":"2020","unstructured":"Shuai M, Huang L (2020) High Expression of hsa_circRNA_001387 in nasopharyngeal carcinoma and the effect on efficacy of radiotherapy. Onco Targets Ther 13:3965\u20133973","journal-title":"Onco Targets Ther"},{"issue":"3","key":"4350_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/sj.emboj.7600070","volume":"23","author":"I Kaufmann","year":"2004","unstructured":"Kaufmann I, Martin G, Friedlein A, Langen H, Keller W (2004) Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase. EMBO J 23(3):616\u2013626","journal-title":"EMBO J"},{"issue":"8","key":"4350_CR16","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/embj.201386537","volume":"33","author":"B Lackford","year":"2014","unstructured":"Lackford B, Yao C, Charles GM, Weng L, Zheng X, Choi EA et al (2014) Fip1 regulates mRNA alternative polyadenylation to promote stem cell self-renewal. EMBO J 33(8):878\u2013889","journal-title":"EMBO J"},{"issue":"4","key":"4350_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ng0497-356","volume":"15","author":"PA Steck","year":"1997","unstructured":"Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH et al (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15(4):356\u201362","journal-title":"Nat Genet"},{"issue":"2","key":"4350_CR18","first-page":"1145","volume":"19","author":"H Qin","year":"2020","unstructured":"Qin H, Qin C (2020) Downregulation of long non-coding RNA NR2F2-AS1 inhibits proliferation and induces apoptosis of nasopharyngeal carcinoma cells by upregulating the expression of PTEN. Oncol Lett 19(2):1145\u20131150","journal-title":"Oncol Lett"},{"issue":"1","key":"4350_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-018-0771-7","volume":"17","author":"C Yang","year":"2018","unstructured":"Yang C, Yuan W, Yang X, Li P, Wang J, Han J et al (2018) Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17\/miR-224 and regulating p21, PTEN expression. Mol Cancer 17(1):19","journal-title":"Mol Cancer"},{"issue":"11","key":"4350_CR20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/kjm2.12443","volume":"37","author":"DD Yuan","year":"2021","unstructured":"Yuan DD, Jia CD, Yan MY, Wang J (2021) Circular RNA hsa_circ_0000730 restrains cell proliferation, migration, and invasion in cervical cancer through miR-942-5p\/PTEN axis. Kaohsiung J Med Sci 37(11):964\u2013972","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"4350_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-019-1040-0","volume":"18","author":"Q Lu","year":"2019","unstructured":"Lu Q, Liu T, Feng H, Yang R, Zhao X, Chen W et al (2019) Circular RNA circSLC8A1 acts as a sponge of miR-130b\/miR-494 in suppressing bladder cancer progression via regulating PTEN. Mol Cancer 18(1):111","journal-title":"Mol Cancer"},{"key":"4350_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2021.101581","volume":"71","author":"Y Lu","year":"2021","unstructured":"Lu Y, Hu X, Yang X (2021) miR-934 promotes breast cancer metastasis by regulation of PTEN and epithelial-mesenchymal transition. Tissue Cell 71:101581","journal-title":"Tissue Cell"},{"issue":"4","key":"4350_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41419-020-2409-0","volume":"11","author":"X Zang","year":"2020","unstructured":"Zang X, Gu J, Zhang J, Shi H, Hou S, Xu X et al (2020) Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression. Cell Death Dis 11(4):215","journal-title":"Cell Death Dis"},{"issue":"1","key":"4350_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3391","volume":"24","author":"L Wang","year":"2022","unstructured":"Wang L, Sang J, Zhang Y, Gao L, Zhao D, Cao H (2022) Circular RNA ITCH attenuates the progression of nasopharyngeal carcinoma by inducing PTEN upregulation via miR-214. J Gene Med 24(1):e3391","journal-title":"J Gene Med"},{"issue":"7483","key":"4350_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP (2014) The multilayered complexity of ceRNA crosstalk and competition. Nature 505(7483):344\u2013352","journal-title":"Nature"},{"issue":"5","key":"4350_CR26","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/ijms19051310","volume":"19","author":"JJ Chan","year":"2018","unstructured":"Chan JJ, Tay Y (2018) Noncoding RNA:RNA regulatory networks in cancer. Int J Mol Sci. 19(5):1310","journal-title":"Int J Mol Sci."},{"key":"4350_CR27","doi-asserted-by":"publisher","first-page":"153303382199527","DOI":"10.1177\/1533033821995278","volume":"20","author":"J Mo","year":"2021","unstructured":"Mo J, Zheng T, Lei L, Dai P, Liu J, He H et al (2021) MicroRNA-1253 suppresses cell proliferation migration and invasion of osteosarcoma by targeting MMP9. Technol Cancer Res Treat 20:1533033821995278","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"4350_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10238-021-00706-y","volume":"21","author":"D Yang","year":"2021","unstructured":"Yang D, Zhang D (2021) miR-1253, a novel tumor suppressor gene in colon cancer, is associated with poor patients prognosis. Clin Exp Med 21(4):563\u2013571","journal-title":"Clin Exp Med"},{"issue":"12","key":"4350_CR29","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1073\/pnas.0400933101","volume":"101","author":"MA Ferraiuolo","year":"2004","unstructured":"Ferraiuolo MA, Lee CS, Ler LW, Hsu JL, Costa-Mattioli M, Luo MJ et al (2004) A nuclear translation-like factor eIF4AIII is recruited to the mRNA during splicing and functions in nonsense-mediated decay. Proc Natl Acad Sci U S A 101(12):4118\u20134123","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4350_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1261\/rna.5230104","volume":"10","author":"CC Chan","year":"2004","unstructured":"Chan CC, Dostie J, Diem MD, Feng W, Mann M, Rappsilber J et al (2004) eIF4A3 is a novel component of the exon junction complex. RNA 10(2):200\u2013209","journal-title":"RNA"},{"issue":"1","key":"4350_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12943-020-01183-9","volume":"19","author":"X Zheng","year":"2020","unstructured":"Zheng X, Huang M, Xing L, Yang R, Wang X, Jiang R et al (2020) The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer 19(1):73","journal-title":"Mol Cancer"},{"key":"4350_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biopha.2018.03.071","volume":"102","author":"S Zhang","year":"2018","unstructured":"Zhang S, Leng T, Zhang Q, Zhao Q, Nie X, Yang L (2018) Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and\/or inhibiting NF-kappaB signaling or PI3K\/AKT\/mTOR pathway. Biomed Pharmacother 102:302\u2013308","journal-title":"Biomed Pharmacother"},{"key":"4350_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.omtn.2019.10.043","volume":"19","author":"W Tang","year":"2020","unstructured":"Tang W, Wang D, Shao L, Liu X, Zheng J, Xue Y et al (2020) LINC00680 and TTN-AS1 stabilized by EIF4A3 promoted malignant biological behaviors of glioblastoma cells. Mol Ther Nucleic Acids 19:905\u2013921","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"4350_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/biom9040153","volume":"9","author":"A Papa","year":"2019","unstructured":"Papa A, Pandolfi PP (2019) The PTEN(-)PI3K axis in cancer. Biomolecules 9(4):153","journal-title":"Biomolecules"},{"issue":"24","key":"4350_CR35","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.7150\/jca.27655","volume":"9","author":"Y Lin","year":"2018","unstructured":"Lin Y, Zhang J, Cai J, Liang R, Chen G, Qin G et al (2018) Systematic analysis of gene expression alteration and co-expression network of eukaryotic initiation factor 4A\u20133 in cancer. J Cancer 9(24):4568\u20134577","journal-title":"J Cancer"},{"issue":"1","key":"4350_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-018-0911-0","volume":"17","author":"R Wang","year":"2018","unstructured":"Wang R, Zhang S, Chen X, Li N, Li J, Jia R et al (2018) EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis. Mol Cancer 17(1):166","journal-title":"Mol Cancer"},{"key":"4350_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.omtn.2019.11.017","volume":"19","author":"Y Li","year":"2020","unstructured":"Li Y, Ren S, Xia J, Wei Y, Xi Y (2020) EIF4A3-induced circ-BNIP3 aggravated hypoxia-induced injury of H9c2 cells by targeting miR-27a-3p\/BNIP3. Mol Ther Nucleic Acids 19:533\u2013545","journal-title":"Mol Ther Nucleic Acids"},{"key":"4350_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.canlet.2020.09.006","volume":"496","author":"C Fan","year":"2021","unstructured":"Fan C, Qu H, Xiong F, Tang Y, Tang T, Zhang L et al (2021) CircARHGAP12 promotes nasopharyngeal carcinoma migration and invasion via ezrin-mediated cytoskeletal remodeling. Cancer Lett 496:41\u201356","journal-title":"Cancer Lett"},{"issue":"2","key":"4350_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/mc.23143","volume":"59","author":"J Yang","year":"2020","unstructured":"Yang J, Zhu D, Liu S, Shao M, Liu Y, Li A et al (2020) Curcumin enhances radiosensitization of nasopharyngeal carcinoma by regulating circRNA network. Mol Carcinog 59(2):202\u2013214","journal-title":"Mol Carcinog"},{"issue":"4","key":"4350_CR40","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/bpa.12829","volume":"30","author":"RK Kanchan","year":"2020","unstructured":"Kanchan RK, Perumal N, Atri P, Chirravuri Venkata R, Thapa I, Klinkebiel DL et al (2020) MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7\u2013H3). Brain Pathol 30(4):732\u2013745","journal-title":"Brain Pathol"},{"issue":"2","key":"4350_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41419-017-0218-x","volume":"9","author":"M Liu","year":"2018","unstructured":"Liu M, Zhang Y, Zhang J, Cai H, Zhang C, Yang Z et al (2018) MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A. Cell Death Dis 9(2):189","journal-title":"Cell Death Dis"},{"key":"4350_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CMAR.S273783","volume":"13","author":"X Ding","year":"2021","unstructured":"Ding X, Zheng J, Cao M (2021) Circ_0004771 accelerates cell carcinogenic phenotypes via suppressing miR-1253-mediated DDAH1 inhibition in breast cancer. Cancer Manag Res 13:1\u201311","journal-title":"Cancer Manag Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04350-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04350-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04350-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T12:22:07Z","timestamp":1666354927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04350-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4350"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04350-x","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"22 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no commercial or other associations that might pose a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Affiliated Nanhua Hospital of University of South China, and informed consents were provided to each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Animal manipulates were conducted in accordance with the guidelines approved by the Committee on the Ethics of Animal Experiments of Affiliated Nanhua Hospital of University of South China.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The informed consent obtained from study participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"357"}}